Engineered M2a macrophages for the treatment of osteoarthritis.

Front Immunol · 2022 · PMC9792488 · PMID 36582221

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

After co-culture with OA-FLS, M2 Mφs showed a trend of transition to the M1 phenotype, with decreased polarization markers of M2 (CD206, ARG1).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.